Department of Critical Care Medicine, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, 200120, China.
J Cardiothorac Surg. 2024 Oct 25;19(1):614. doi: 10.1186/s13019-024-03116-9.
This study aims to compare the efficacy of the Age-adjusted Charlson Comorbidity Index (ACCI) and the Elixhauser-Van Walraven Comorbidity Index (ECI-VW) in predicting mortality risk among patients undergoing heart valve surgery.
Clinical data were extracted from the INSPIRE Database using R language. The Receiver Operating Characteristic (ROC) Curve was employed to assess the predictive accuracy of ACCI and ECI-VW for in-hospital all-cause mortality and post-surgical all-cause mortality at 7 and 28 days. Subgroup analysis was conducted to validate the application efficacy, and the optimal cutoff value was identified.
The study included 996 patients, with 931 survivors and 65 cases of in-hospital all-cause mortality. The area under the curve (AUC) for ACCI in predicting in-hospital all-cause mortality was 0.658 (95% CI: 0.584, 0.732), while the AUC for ECI-vw in predicting the same outcome was 0.663 (95% CI: 0.584, 0.741). For predicting all-cause mortality within 7 days post-surgery, the AUC of ACCI was 0.680 (95% CI: 0.04, 0.56), and for ECI-vw, it was 0.532 (95% CI: 0.353, 0.712). Regarding the prediction of all-cause mortality within 28 days after surgery, the AUC for ACCI was 0.724 (95% CI: 0.622, 0.827), and for ECI-vw, it was 0.653 (95% CI: 0.538, 0.69). Patients were categorized into two groups based on the ACCI cutoff value of 3.5, including Group 1 (ACCI < 3.5 points, 823 cases) and Group 2 (ACCI > 3.5 points, 173 cases). The overall survival rate for these two patient groups was calculated using the Kaplan-Meier method, revealing that the 28-day postoperative survival rate for patients in Group 1 was significantly higher than that for patients in Group 2 (P < 0.0001).
ACCI demonstrates significant predictive value for in-hospital all-cause mortality within 28 days following cardiac valve disease surgery. Patients presenting with an ACCI greater than 3.5 exhibit an increased risk of mortality within 28 days post-surgery compared to those with an ACCI less than 3.5. This finding suggests that the ACCI can serve as a preliminary tool for assessing the prognosis of patients undergoing this type of surgical intervention.
本研究旨在比较年龄调整 Charlson 合并症指数(ACCI)和 Elixhauser-Van Walraven 合并症指数(ECI-VW)在预测心脏瓣膜手术后患者死亡风险方面的疗效。
使用 R 语言从 INSPIRE 数据库中提取临床数据。采用受试者工作特征(ROC)曲线评估 ACCI 和 ECI-VW 对住院全因死亡率和术后 7 天和 28 天全因死亡率的预测准确性。进行亚组分析以验证应用效果,并确定最佳截断值。
本研究纳入 996 例患者,其中 931 例存活,65 例发生院内全因死亡。ACCI 预测院内全因死亡率的曲线下面积(AUC)为 0.658(95%CI:0.584,0.732),而 ECI-vw 预测同一结局的 AUC 为 0.663(95%CI:0.584,0.741)。对于预测术后 7 天内全因死亡率,ACCI 的 AUC 为 0.680(95%CI:0.04,0.56),而 ECI-vw 的 AUC 为 0.532(95%CI:0.353,0.712)。对于预测术后 28 天内全因死亡率,ACCI 的 AUC 为 0.724(95%CI:0.622,0.827),而 ECI-vw 的 AUC 为 0.653(95%CI:0.538,0.69)。根据 ACCI 截断值 3.5,患者被分为两组,包括组 1(ACCI<3.5 分,823 例)和组 2(ACCI>3.5 分,173 例)。使用 Kaplan-Meier 方法计算两组患者的总生存率,结果显示组 1患者的 28 天术后生存率明显高于组 2患者(P<0.0001)。
ACCI 对心脏瓣膜病手术后 28 天内的院内全因死亡率具有显著的预测价值。ACCI 大于 3.5 分的患者在术后 28 天内的死亡率明显高于 ACCI 小于 3.5 分的患者。这一发现表明,ACCI 可以作为评估此类手术干预患者预后的初步工具。